Buy & Sell Merck Tbk. - MERK Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp1.2T | +15.81% |
| Cost of Revenue | Rp629.36B | -0.74% |
| Gross Profit | Rp571.3B | +41.88% |
| General Expenses, Depreciation, Interest | Rp250.87B | +19.92% |
| Operating Profit | Rp320.43B | +65.62% |
| Other Income | Rp6.9B | +334.33% |
| EBT | Rp327.34B | +67.81% |
| Taxes | -Rp83.44B | +100.58% |
| Net Income | Rp243.9B | +58.93% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp1.27T | +32.95% |
| Total Liabilities | Rp296.49B | +98.1% |
| Total Equity | Rp975.71B | +20.87% |
| Total Liabilities & Total Equity | Rp1.27T | +32.95% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q1
’25
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp376.52B | +575.84% |
| CF from Investment | Rp15.85B | -4.91% |
| CF from Financing | Rp84.5B | -44.7% |
| Net Cash Flow | Rp276.17B | -342.78% |